FluoretiQ
2 known investors
FluoretiQ develops rapid point-of-care diagnostic tests for bacterial infections in human and animal health, designed to support clinicians and veterinarians with faster antimicrobial resistance detection to inform prescribing decisions. The company's tests reduce diagnostic turnaround time from 3 days to 30 minutes.